Skip to content

Multicenter Study of Impulse Oscillometry in Chinese

Multicenter Study of Impulse Oscillometry in Chinese

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03467880
Enrollment
4000
Registered
2018-03-16
Start date
2016-09-30
Completion date
2018-12-31
Last updated
2018-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease, Healthy Subjects, Interstitial Lung Disease, Upper Airway Obstruction

Keywords

Impulse Oscillometry, Chinese, Healthy Subjects, Chronic Obstructive Pulmonary Disease, Asthma, Interstitial Lung Disease, Upper Airway Obstruction, Reference Values

Brief summary

The purpose of this study is to establish the reference values of impulse oscillometry (IOS) in healthy Chinese, and compare the indices of IOS in patients with lung disease, such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease (ILD), and upper airway Obstruction (UAO).

Interventions

OTHERClinical Observation

No treatment given but observation with IOS

Sponsors

Beijing Hospital
CollaboratorOTHER_GOV
Beijing Children's Hospital
CollaboratorOTHER
Shanghai Zhongshan Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Third Military Medical University
CollaboratorOTHER
Xiangya Hospital of Central South University
CollaboratorOTHER
People's Hospital of Anshun City of Guizhou Province
CollaboratorOTHER
Shanghai Pulmonary Hospital, Shanghai, China
CollaboratorOTHER
Beijing Chao Yang Hospital
CollaboratorOTHER
Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
4 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

for healthy subjects: * life-long non-smokers * no symptoms and history of chronic cardiopulmonary diseases (chronic bronchitis, asthma, lung cancer, pulmonary fibrosis, pulmonary tuberculosis, chronic heart diseases, etc.) * no abnormal findings on physical examination * written informed consent was obtained Inclusion Criteria for COPD: * Diagnosis of chronic obstructive pulmonary disease (COPD), as classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines and post-bronchodilator FEV1/FVC (forced vital capacity) \< 70%. Inclusion Criteria for asthma: * Diagnosis of asthma, as classified by national and international asthma guidelines. Inclusion Criteria for ILD: * ILD diagnosis confirmed by lung biopsy, X ray or BALF analysis. Inclusion Criteria for UAO: * Diagnosis of UAO.

Exclusion criteria

for healthy subjects: * upper or lower respiratory infection within 4 weeks * long-term exposure to harmful gas or particles * using β-blocker for treatment * pregnant women, epileptic * other diseases or surgeries potentially affecting lung function

Design outcomes

Primary

MeasureTime frameDescription
Airway resistanceone minuteThe indices of Airway resistance include total respiratory impedance (Zrs).

Secondary

MeasureTime frameDescription
forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, and maximum midexpiratory flow (MMEF).one minuteThe indices of spirometry include forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, and maximum midexpiratory flow (MMEF).

Countries

China

Contacts

Primary ContactJinping Zheng, MD
jpzhenggy@163.com+86-20-83062729

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026